Back to Search Start Over

EyePoint Pharmaceuticals Highlights Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Source :
Entertainment Close-up. August 26, 2024
Publication Year :
2024

Abstract

EyePoint Pharmaceuticals, a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, reported that the Company granted non-statutory stock options to [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Entertainment Close-up
Publication Type :
Periodical
Accession number :
edsgcl.806098889